Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.71K | 66.57K | 3.56K | 0.00 | 358.14K | Gross Profit |
1.71K | 66.57K | 3.56K | 0.00 | 358.14K | EBIT |
-4.84M | -38.95M | -3.83M | -3.67M | ― | EBITDA |
11.98M | -40.78M | -5.11M | -4.57M | -20.86M | Net Income Common Stockholders |
-21.25M | -36.55M | -7.99M | -3.63M | ― |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.98M | 4.12M | 3.49M | 13.36M | 18.73M | Total Assets |
31.26M | 55.62M | 45.87M | 16.93M | 19.89M | Total Debt |
0.00 | 0.00 | 0.00 | 348.90K | 0.00 | Net Debt |
-2.97M | -4.11M | -3.44M | -11.46M | -18.67M | Total Liabilities |
1.25M | 4.97M | 5.65M | 947.08K | 350.37K | Stockholders Equity |
30.02M | 50.65M | 40.22M | 16.03M | 19.54M |
Cash Flow | Free Cash Flow | |||
-5.33M | -37.39M | -4.63M | -5.25M | ― | Operating Cash Flow |
-5.33M | -35.79M | -4.63M | -3.50M | ― | Investing Cash Flow |
4.30M | 948.24K | -8.50M | -3.31M | 0.00 | Financing Cash Flow |
0.00 | 35.67M | 4.87M | 0.00 | 15.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | C$1.85B | 12.14 | 7.57% | 4.15% | -0.17% | 76.67% | |
74 Outperform | $2.27B | 6.87 | 9.38% | 27.87% | 3.08% | -30.22% | |
68 Neutral | C$3.57B | 73.25 | 3.62% | 5.65% | -2.25% | -3.28% | |
56 Neutral | $7.00B | 3.44 | -4.86% | 5.89% | -0.09% | -48.37% | |
45 Neutral | $1.24B | ― | -38.67% | 4.72% | ― | -438.52% | |
44 Neutral | $21.85M | ― | -56.79% | ― | -27.09% | -681.10% | |
41 Neutral | £48.86M | ― | -58.84% | ― | ― | -549.19% |